Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
17.5M
-
Shares change
-
+22.1K
-
Total reported value, excl. options
-
$132M
-
Value change
-
-$233K
-
Put/Call ratio
-
2.91
-
Number of buys
-
39
-
Number of sells
-
-47
-
Price
-
$7.55
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q2 2021
112 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q2 2021.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.5M shares
of 65.9M outstanding shares and own 26.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.64M shares), VANGUARD GROUP INC (2.11M shares), Skylands Capital, LLC (1.77M shares), AVENIR CORP (1.37M shares), Redmile Group, LLC (1.3M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1M shares), Sargent Investment Group, LLC (856K shares), Neuberger Berman Group LLC (847K shares), STATE STREET CORP (714K shares), and GEODE CAPITAL MANAGEMENT, LLC (694K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.